1-7 of 7
Pär Josefsson
Close
Sort by
Journal Articles

Lymphoma Patients Treated without Anthracyclines Have Negligible Risk of Cardiotoxicity: A Nationwide Cohort Study

Joachim Baech, Steen Moeller Hansen, Peter Enemark Lund, Christian Torp-Pedersen, Peter Soegaard, Peter de Nully Brown, MD PhD, Henrik Frederiksen, Judit Mészáros Jørgensen, Joern Starklint, Pär Josefsson, MD PhD, Christian Bjørn Poulsen, Hans Erik Johnsen, MD Professor, Tarec Christoffer El-Galaly, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2843.
https://doi.org/10.1182/blood.V130.Suppl_1.2843.2843
Published: 2017
Journal Articles

The Impact of Pre-Therapeutic Haemoglobin Levels on the Outcome of Patients with Diffuse Large B-Cell Lymphoma Treated with Anthracycline Containing Chemotherapy before and after the Introduction of Rituximab: A Nation-Wide Cohort Study

Michael Roost Clausen, MD, Sinna Pilgaard Ulrichsen, MSc, Thomas Stauffer Larsen, MD PhD, Bodil Himmelstrup, MD PhD, Dorthe Rønnov-Jessen, MD, Per Trøllund Pedersen, MD, Jakob Madsen, MD, Robert Schou Pedersen, MD, Pär Josefsson, MD PhD, Jette Sønderskov Gørløv, MD, Mette Nørgaard, MD PhD, Francesco d'Amore, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1566.
https://doi.org/10.1182/blood.V130.Suppl_1.1566.1566
Published: 2017
Journal Articles

Rituximab Maintenance after First Line Immunochemotherapy Improves Overall Survival in Patients with Follicular Lymphoma

Adam Vilmar, PhD MD, Bente Arboe, Par Josefsson, MD PhD, Christian Poulsen, Jacob Haaber Christensen, Judit Jørgensen, MD PhD, Paw Jensen, Jørn Starklint, Per Troellund Pedersen, Michael Pedersen, Peter de Nully Brown, MD PhD
Journal: Blood
Blood (2016) 128 (22): 1781.
https://doi.org/10.1182/blood.V128.22.1781.1781
Published: 2016
Journal Articles

A Different Ontogenesis for CLL Cases Carrying Stereotyped Antigen Receptors: Molecular and Computational Evidence

Nikos Darzentas, Anastasia Hadzidimitriou, Fiona Murray, Katerina Hatzi, Par Josefsson, Nikolaos Laoutaris, Carol Moreno, Achilles Anagnostopoulos, Jesper Jurlander, Athanasios Tsaftaris, Nicholas Chiorazzi, Chrysoula Belessi, Paolo Ghia, Richard Rosenquist, Frederic Davi, Kostas Stamatopoulos
Journal: Blood
Blood (2008) 112 (11): 777.
https://doi.org/10.1182/blood.V112.11.777.777
Published: 2008
Journal Articles

CLLU1 expression analysis adds prognostic information to risk prediction in chronic lymphocytic leukemia

Pär Josefsson, Christian H. Geisler, Henrik Leffers, Jørgen H. Petersen, Mette K. Andersen, Jesper Jurlander, Anne Mette Buhl
Journal: Blood
Blood (2007) 109 (11): 4973–4979.
https://doi.org/10.1182/blood-2006-11-054916
Published: 2007
Journal Articles

Validation of the Prognostic Significance of the Disease Specific Gene CLLU1 in Chronic Lymphocytic Leukemia.

Par Josefsson, MD, Jesper Jurlander, MD, PhD, Christian H. Geisler, MDD.MS, Lone B. Pedersen, Lone Bach, Mette K. Andersen, MD, Henrik Leffers, MS, Anne Mette Buhl, PhD
Journal: Blood
Blood (2005) 106 (11): 709.
https://doi.org/10.1182/blood.V106.11.709.709
Published: 2005
Journal Articles

A Novel and Disease Specific Gene in Chronic Lymphocytic Leukemia.

Anne Mette Buhl, PhD, Jesper Jurlander, MD, PhD, Lone B. Pedersen, Par Josefsson, MD, Christian H. Geisler, MD, DMsc, Henrik Leffers, MSc
Journal: Blood
Blood (2004) 104 (11): 770.
https://doi.org/10.1182/blood.V104.11.770.770
Published: 2004